|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lagos-Quintana M, Rauhut R, Lendeckel W
and Tuschl T: Identification of novel genes coding for small
expressed RNAs. Science. 294:853–858. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ambros V: MicroRNA pathways in flies and
worms: Growth, death, fat, stress and timing. Cell. 113:673–676.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yu X, Song H, Xia T, Han S, Xiao B, Luo L,
Xi Y and Guo J: Growth inhibitory effects of three miR-129 family
members on gastric cancer. Gene. 532:87–93. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bandres E, Agirre X, Bitarte N, Ramirez N,
Zarate R, Roman-Gomez J, Prosper F and Garcia-Foncillas J:
Epigenetic regulation of microRNA expression in colorectal cancer.
Int J Cancer. 125:2737–2743. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen X, Hu H, Guan X, Xiong G, Wang Y,
Wang K, Li J, Xu X, Yang K and Bai Y: CpG island methylation status
of miRNAs in esophageal squamous cell carcinoma. Int J Cancer.
130:1607–1613. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dyrskjot L, Ostenfeld MS, Bramsen JB,
Silahtaroglu AN, Lamy P, Ramanathan R, Fristrup N, Jensen JL,
Andersen CL, Zieger K, et al: Genomic profiling of microRNAs in
bladder cancer: miR-129 is associated with poor outcome and
promotes cell death in vitro. Cancer Res. 69:4851–4860. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee
DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mosmann T: Rapid colorimetric assay for
cellular growth and survival: Application to proliferation and
cytotoxicity assays. J Immunol Methods. 65:55–63. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shridhar R, Zhang J, Song J, Booth BA,
Kevil CG, Sotiropoulou G, Sloane BF and Keppler D: Cystatin M
suppresses the malignant phenotype of human MDA-MB-435S cells.
Oncogene. 23:2206–2215. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dweep H, Sticht C, Pandey P and Gretz N:
miRWalk-database: Prediction of possible miRNA binding sites by
‘walking’ the genes of three genomes. J Biomed Inform. 44:839–847.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Griffiths-Jones S, Grocock RJ, van Dongen
S, Bateman A and AJ: miRBase Enright: microRNA sequences, targets
and gene nomenclature. Nucleic Acids Res (Database issue).
34:D140–D144. 2006. View Article : Google Scholar
|
|
16
|
Ren Y, Busch RK, Perlaky L and Busch H:
The 58-kDa microspherule protein (MSP58), a nucleolar protein,
interacts with nucleolar protein p120. Eur J Biochem. 253:734–742.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Eriksson JE, Dechat T, Grin B, Helfand B,
Mendez M, Pallari HM and Goldman RD: Introducing intermediate
filaments: From discovery to disease. J Clin Invest. 119:1763–1771.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Leader M, Collins M, Patel J and Henry K:
Vimentin: An evaluation of its role as a tumour marker.
Histopathology. 11:63–72. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gumbiner BM: Regulation of
cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol.
6:622–634. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Calin GA and Croce CM: MicroRNA-cancer
connection: The beginning of a new tale. Cancer Res. 66:7390–7394.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu X, Luo L, Wu Y, Yu X, Liu Y, Yu X, Zhao
X, Zhang X, Cui L, Ye G, et al: Gastric juice miR-129 as a
potential biomarker for screening gastric cancer. Med Oncol.
30:3652013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xiao Y, Li X, Wang H, Wen R, He J and Tang
J: Epigenetic regulation of miR-129-2 and its effects on the
proliferation and invasion in lung cancer cells. J Cell Mol Med.
19:2172–2180. 2015.PubMed/NCBI
|
|
23
|
Chiang Y, Song Y, Wang Z, Chen Y, Yue Z,
Xu H, Xing C and Liu Z: Aberrant expression of miR-203 and its
clinical significance in gastric and colorectal cancers. J
Gastrointest Surg. 15:63–70. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shen R, Pan S, Qi S, Lin X and Cheng S:
Epigenetic repression of microRNA-129-2 leads to overexpression of
SOX4 in gastric cancer. Biochem Biophys Res Commun. 394:1047–1052.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang YW, Liu JC, Deatherage DE, Luo J,
Mutch DG, Goodfellow PJ, Miller DS and Huang TH: Epigenetic
repression of microRNA-129-2 leads to overexpression of SOX4
oncogene in endometrial cancer. Cancer Res. 69:9038–9046. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li M, Tian L, Wang L, Yao H, Zhang J, Lu
J, Sun Y, Gao X, Xiao H and Liu M: Down-Regulation of miR-129-5p
inhibits growth and induces apoptosis in laryngeal squamous cell
carcinoma by targeting APC. PLoS One. 8:e778292013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ogawa R, Ishiguro H, Kuwabara Y, Kimura M,
Mitsui A, Katada T, Harata K, Tanaka T and Fujii Y: Expression
profiling of micro-RNAs in human esophageal squamous cell carcinoma
using RT-PCR. Med Mol Morphol. 42:102–109. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Buscaglia LE and Li Y: Apoptosis and the
target genes of microRNA-21. Chin J Cancer. 30:371–380. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Selcuklu SD, Donoghue MT and Spillane C:
miR-21 as a key regulator of oncogenic processes. Biochem Soc
Trans. 37:918–925. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tili E, Michaille JJ, Gandhi V, Plunkett
W, Sampath D and Calin GA: miRNAs and their potential for use
against cancer and other diseases. Future Oncol. 3:521–537. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Toiyama Y, Takahashi M, Hur K, Nagasaka T,
Tanaka K, Inoue Y, Kusunoki M, Boland CR and Goel A: Serum miR-21
as a diagnostic and prognostic biomarker in colorectal cancer. J
Natl Cancer Inst. 105:849–859. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
